| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | GILD | Common Stock | Options Exercise | +3,678 | +11% | 36,956 | 10 Aug 2024 | Direct | F1 | ||
| transaction | GILD | Common Stock | Tax liability | $72,187 | -980 | -2.7% | $73.66 | 35,976 | 10 Aug 2024 | Direct |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | GILD | Restricted Stock Unit | Options Exercise | -3,678 | -21% | 14,084 | 10 Aug 2024 | Common Stock | 3,678 | Direct | F1, F2 |
| Id | Content |
|---|---|
| F1 | Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. |
| F2 | The restricted stock units have a three year vesting schedule. 33.33% vest on each yearly anniversary of the date of grant until fully vested. |